Market report
Dermatological drug tenders in Czechia — market report, September 2025
Dermatological drug tenders in Czechia in September 2025: 7,228 tenders published (+21% month on month, +27% year on year), estimated at €292,962 in total, and 7,251 contracts awarded (+21% month on month, +28% year on year), worth €12,678,450 (awarded value). Buyers with the most tenders: Krajská nemocnice T. Bati, a. s. (2,382), Krajská zdravotní, a.s. (826) and Fakultní nemocnice Brno (499); most contracts won: ROCHE s.r.o. (175), ViaPharma s.r.o. (167) and Janssen-Cilag s.r.o. (118). On average 1.7 bids per contract; 60% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 7,228
- Contracts awarded
- 7,251
- Contract value awarded
- €12,678,450
- Bids per contract
- 1.7
The highlighted bar is September 2025. Hover a bar for its figure; the table below has every value.
| Figure | September 2025 | August 2025 | Change | September 2024 | Change |
|---|---|---|---|---|---|
| Tenders published | 7,228 | 5,988 | +21% | 5,695 | +27% |
| Estimated value | €292,962 | €97,682 | +200% | €2,002,721 | -85% |
| Buyers | 31 | 30 | +3% | 31 | 0% |
| Contracts awarded | 7,251 | 6,004 | +21% | 5,682 | +28% |
| Contract value (awarded) | €12,678,450 | €4,347,195 | +192% | — | — |
| Winners | 290 | 264 | +10% | 252 | +15% |
| Bids per contract | 1.7 | 1.8 | — | — | — |
| Single-bid contracts | 60% | 40% | — | — | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | ROCHE s.r.o. | 175 |
| 2 | ViaPharma s.r.o. | 167 |
| 3 | Janssen-Cilag s.r.o. | 118 |
| 4 | AbbVie s.r.o. | 100 |
| 5 | Amgen s.r.o. | 91 |
| 6 | Takeda Pharmaceuticals Czech Republic s.r.o. | 91 |
| 7 | Gilead Sciences s.r.o. | 88 |
| 8 | Merck Sharp & Dohme s.r.o. | 82 |
| 9 | FAGRON a.s. | 79 |
| 10 | Avenier a.s. | 73 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Dermatological and musculoskeletal drugs
Questions and answers
- How many dermatological drug tenders were published in Czechia in September 2025?
- 7,228 (by 31 buyers); for comparison, August 2025: 5,988, September 2024: 5,695.
- Who won the most dermatological drug tenders in Czechia in September 2025?
- By number of contracts: ROCHE s.r.o. (175), ViaPharma s.r.o. (167), Janssen-Cilag s.r.o. (118), AbbVie s.r.o. (100) and Amgen s.r.o. (91); 290 companies won contracts in all.
- Which buyers published the most dermatological drug tenders in September 2025?
- Krajská nemocnice T. Bati, a. s. (2,382), Krajská zdravotní, a.s. (826), Fakultní nemocnice Brno (499), Fakultní nemocnice Bulovka (467) and Nemocnice České Budějovice, a.s. (340).
- How competitive were dermatological drug tenders in Czechia in September 2025?
- On average 1.7 bids per contract (20 contracts with a known number of bids); 60% of contracts had a single bid.
- What were the contracts worth in September 2025?
- €12,678,450 (awarded value, 7,251 contracts); median about €770,000.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.